Fierce JPM Week 2027
Fierce Life Sciences' event in San Francisco during J.P. Morgan Healthcare Conference week, with an in-person program and a virtual stream. It draws biopharma executives, investors and dealmakers.
Tuesday to Wednesday · 2 days
Hyatt Regency San Francisco
Organizer
Not published
Exhibitor list
Every year
How often it's held
Checked November 10, 2026
Reported attendance
500+
in-person attendees · year not stated
Reported exhibitors
Not published
About Fierce JPM Week 2027
Fierce JPM Week is a two-day biopharma conference run by Questex's Fierce Pharma and Fierce Biotech in San Francisco. It runs during the same January week as the J.P. Morgan Healthcare Conference but it's a separate event. The 2027 edition takes place live on 12 and 13 January 2027, with a virtual program the following week. The organizer's venue page lists the Hyatt Regency San Francisco on the Embarcadero. The organizer cites more than 500 in-person and 4,000 virtual attendees without naming a year.
4,000+
Virtual attendees
75%
VP level and above
200+
Companies represented
65+
Expert speakers
55%
From biotech, pharma and medical device companies
What happens at Fierce JPM Week
Fierce JPM Week is an editorial conference built around panels, interviews and networking. The organizer promises two full days of content from its editorial team, with Fierce Pharma and Fierce Biotech editors on site.
The 2027 program theme is biopharma's next big bets. The home page lists topics such as China licensing, larger biotech rounds, the IPO market and the patent cliff. Obesity drugs beyond GLP-1s, psychedelics and direct-to-consumer models are also on the list.
Networking runs through breakfasts, lunches, breaks and a cocktail reception. Attendees can book one-to-one meetings in the event app and use a dedicated meeting area.
The in-person days are followed by a virtual event on 20 to 22 January 2027. The 2027 agenda page doesn't list sessions yet.
How Fierce JPM Week relates to the J.P. Morgan Healthcare Conference
Fierce JPM Week isn't part of the J.P. Morgan Healthcare Conference. Questex's Fierce brands run it, and the organizer doesn't claim any tie to J.P. Morgan beyond the timing.
The 45th J.P. Morgan Healthcare Conference runs 11 to 14 January 2027 in San Francisco. J.P. Morgan says that event is by invitation only. Fierce JPM Week, by contrast, sells open registration subject to approval.
Many people in town that week combine several events. Our pages cover the J.P. Morgan Healthcare Conference 2027 and Biotech Showcase 2027, which run the same week.
Who attends Fierce JPM Week
Fierce JPM Week draws senior biopharma executives, investors and service providers. The home page cites 500+ in-person attendees, 4,000+ virtual attendees and 75% at VP level and above, without a year.
- Chairman/CEO30%
- VP/EVP/SVP21%
- Other C-level15%
- Director14%
- Owner/Principal9%
- Manager5%
- Staff4%
- Other2%
From the organizer's 2027 partnering page, which doesn't give the year of the data.fiercejpmweek.com ↗
- Biotech26%
- Consultant14%
- Pharmaceutical12%
- Technology/Software11%
- Advertising/PR/Marketing agency6%
- CRO5%
- Medical devices and diagnostics5%
- CDMO5%
- Financial services3%
- Digital health2%
- Other11%
From the organizer's 2027 partnering page, which doesn't give the year of the data. Ten named types plus Other.fiercejpmweek.com ↗
The organizer's pages don't all agree. The who's attending page shows 3,500+ virtual attendees and 69% at VP level and above. It also says 55% come from biotech, pharma and medical device companies.
The partnering page breaks the audience down without naming a year. Chairmen and CEOs make up 30%, and VPs, EVPs and SVPs another 21%. By company type, biotech leads at 26%, ahead of consultants at 14% and pharma at 12%.
The organizer says 200+ companies were represented in 2026. The executives page cites 400+ companies across biotech, pharma and investment.
Attendance and exhibitors by year
As the organizer reports them. What's counted varies between events, so compare with care.
| Edition | Attendance |
|---|---|
| Not stated | 500+in-person attendees in San FranciscoOrganizer's home page figure, with no year given. The organizer also cites 4,000+ virtual attendees.fiercejpmweek.com ↗ |
Companies at Fierce JPM Week 2026
The 2026 edition drew big pharma, biotech start-ups, investors and service firms. Most names below come from the organizer's 2026 speaker page and list of companies represented in 2026.
Sponsors (8)AlphaSense, Cognizant, Komodo Health and 5 more
- AlphaSense · 2026Sponsor, Sara Mallatt spoke on AI in portfolio strategy
- Cognizant · 2024Named as a 2024 sponsor by Questex
- Komodo Health · 2024Named as a 2024 sponsor by Questex
- PhRMA · 2024Named as a 2024 sponsor by Questex
- Oracle · 2024Named as a 2024 sponsor by Questex
- Thermo Fisher Scientific · 2024Named as a 2024 sponsor by Questex
- Alkermes · 2024Named as a 2024 sponsor by Questex
- H1 · 2024Named as a 2024 sponsor by Questex
Speakers' companies (22)Novartis, Genentech, Novo Nordisk and 19 more
- Novartis · 2026Victor Bulto, President, US and Ronny Gal, Ph.D., Chief Strategy & Growth Officer
- Genentech · 2026Fritz Bittenbender, Senior Vice President and Head of Public Affairs & Access and Ashley Magargee, Chief Executive Officer
- Novo Nordisk · 2026Ludovic Helfgott, EVP of Product & Portfolio Strategy and Jacob Petersen, SVP, Global Research
- Eli Lilly and Company · 2026Ruth Gimeno, Group Vice President, Diabetes, Obesity & Cardiometabolic Research and Early Clinical Development
- GSK · 2026Kaivan Khavandi, Senior Vice President, Global Head, Respiratory, Immunology & Inflammation, Research & Development and Dr. Chris Sheldon, Senior Vice President & Global Head of Business Development
- Merck · 2026Elizabeth Naldi-Jacob, Vice President, Business Development and Licensing Head, HQ Transactions & Corporate Development
- Astellas · 2026Naoki Okamura, President and Chief Executive Officer and Adam Pearson, Chief Strategy Officer
- Bristol Myers Squibb · 2026Wendy Bartie, Executive Vice President, Corporate Affairs
- Regeneron · 2026Boaz Hirshberg, MD, Senior Vice President, Clinical Development Unit Head, Internal Medicine
- Sandoz · 2026Richard Saynor, Chief Executive Officer
- Novo Holdings · 2026Anna Fan, Ph.D., Senior Partner, Venture Investments and Søren Møller, Ph.D., Managing Partner, Seed Investments
- Sofinnova Investments · 2026Maha Katabi, PhD, CFA, General Partner
- McKinsey & Company · 2026Greg Graves, Senior Partner
- Snowflake · 2026Kelci MiClaus, Head of Life Sciences AI
- Komodo Health · 2026Arif Nathoo, CEO and Co-Founder
- H1 · 2026Ariel Katz, CEO and Co-founder
- Charles River Laboratories · 2026Steven Bulera, PhD, DABT, Corporate Vice President, Chief Scientific Officer, Discovery and Safety Assessment
- Capgemini · 2026Thorsten Rall, Global Life Sciences Industry Leader
- J.P. Morgan · 2026Wonhee Oh, VP HC Investment Banking
- Acadia Pharmaceuticals · 2026Catherine Owen Adams, CEO
- PhRMA · 2026Robert Zirkelbach, Chief Public Affairs Officer & Head of Strategic Initiatives
- Antheia · 2026CEO Christina Smolke on a panel about onshoring pharma supply chains, 13 January 2026
Big pharma was heavily represented, from Novartis and Genentech to Novo Nordisk and Lilly. Investors included Novo Holdings and Sofinnova, and J.P. Morgan itself sent a healthcare banker to speak.
Exhibiting at Fierce JPM Week
Fierce JPM Week doesn't run an exhibition hall. Vendors take part through custom partnerships that can include tabletop displays, demo stations and onsite activations.
Sales and business development staff need the vendor and service provider pass at $2,195, checked in November 2026. Group discounts don't apply to that pass.
Meeting tables in the meeting lounge are part of the networking packages. Teams planning several meetings that week may want meeting scheduling software.
Sponsors and partners at Fierce JPM Week
Every Fierce JPM Week partnership is custom, according to the partnering page. It groups options into thought leadership, networking, branding and lead generation.
Thought leadership covers keynotes, standalone sessions and panel seats. Networking options include hosted meals, receptions and sponsored breaks. Branding covers items like registration, Wi-Fi, lanyards and a headshot lounge.
The 2027 partners page doesn't name any partners yet. For 2024, Questex named sponsors including Cognizant, Komodo Health, PhRMA, Oracle, Thermo Fisher Scientific and Alkermes.
Companies can request the 2027 prospectus through a form. Prices aren't published. Teams comparing packages can see how sponsorship software tracks deliverables.
The event's tech
We couldn't identify a third-party registration platform on the event's website.
Fierce JPM Week attendee list, sponsor list and company list
Exhibitor list
Not published
Sponsor list
Published
Attendee list
Not published or sold
Fierce JPM Week doesn't publish an attendee list. The closest public resource is the organizer's list of companies represented in 2026, with job titles but no names.
Partners can buy access to attendees. The partnering page lists unfiltered attendee lead lists among its lead generation options.
Questex warns about list scams. Its registration page says emails offering its attendee lists aren't affiliated with Questex and are fraud.
Our guide explains how to find who's attending an event. We also compare event intelligence platforms that track who goes where.
See who's attending Fierce JPM Week
Organizers don't publish attendee lists. These event intelligence platforms show which companies and roles are likely to attend and help you book meetings. How to find who's attending
Speakers at Fierce JPM Week 2027
Fierce JPM Week hasn't announced its 2027 speakers yet. The 2027 agenda page is still empty, and the speaker menu only shows 2026.
Fierce JPM Week hasn't announced its 2027 speakers yet. Below is who spoke at past editions.
At the 2026 edition, speakers included Genentech CEO Ashley Magargee, Astellas CEO Naoki Okamura and Sandoz CEO Richard Saynor. The 2026 speaker page also listed Novartis US president Victor Bulto and Acadia CEO Catherine Owen Adams.
Fierce editors and writers also appeared on the 2026 speaker list. People from pharma, biotech, device, diagnostics, healthcare and advocacy groups can pitch sessions through the call for speakers. Vendors can buy keynotes and panel seats through partnerships.
Who spoke at Fierce JPM Week 2026 (58)
- Catherine Owen Adams, CEO, Acadia Pharmaceuticals
- Anna Asberg, SVP, IT & CIO, Gilead Sciences
- Wendy Bartie, Executive Vice President, Corporate Affairs, Bristol Myers Squibb
- Fritz Bittenbender, Senior Vice President and Head of Public Affairs & Access, Genentech
- Paul Bridges, PhD, President of Consulting, Parexel
- Steven Bulera, PhD, DABT, Corporate Vice President, Chief Scientific Officer, Discovery and Safety Assessment, Charles River Laboratories
- Victor Bulto, President, US, Novartis
- Manu Chakravarthy, SVP and Global Head of Cardiovascular, Renal and Metabolism (CVRM) Product Development, Roche-Genentech
- Dr. S. Chakra Chennubhotla, Co-Founder and CEO, PredxBio
- Rosemary Coates, Executive Director, Reshoring Institute
- Deepti Cole, Industry VP of Life Sciences, phData
- Anna Fan, Ph.D., Senior Partner, Venture Investments, Novo Holdings
- Stephen Farrelly, Global Healthcare Lead, ING Bank
- Kristen Fortney, CEO, BioAge Labs
- Ronny Gal, Ph.D., Chief Strategy & Growth Officer, Novartis
- Ruth Gimeno, Group Vice President, Diabetes, Obesity & Cardiometabolic Research and Early Clinical Development, Eli Lilly and Company
- Greg Graves, Senior Partner, McKinsey & Company
- Shalabh Gupta, MD, Founder, Chairman of the Board of Directors and CEO, Unicycive Therapeutics
- Ludovic Helfgott, EVP of Product & Portfolio Strategy, Novo Nordisk
- Boaz Hirshberg, MD, Senior Vice President, Clinical Development Unit Head, Internal Medicine, Regeneron
- Douglas Jermasek, M.B.A., Executive Vice President, Corporate Strategy, Unicycive Therapeutics
- Wetteny Joseph, Executive Vice President and Chief Financial Officer, Zoetis
- Maha Katabi, PhD, CFA, General Partner, Sofinnova Investments
- Ariel Katz, CEO and Co-founder, H1
- Deniz Kent, Co-Founder and CEO, Prolific Machines
- Dr. Ghazanfar (Sunny) Khan, Chief Medical Officer, Evidation Health
- Kaivan Khavandi, Senior Vice President, Global Head, Respiratory, Immunology & Inflammation, Research & Development, GSK
- Christoph Koenen, Head of Clinical Development & Operations, Bayer Pharma
- Ashley Magargee, Chief Executive Officer, Genentech
- Sara Mallatt, Director of Healthcare Research, AlphaSense
- Wyatt McDonnell, CEO, Infinimmune
- Mark C. McKenna, Founder, Chairman & CEO, Mirador Therapeutics
- Kelci MiClaus, Head of Life Sciences AI, Snowflake
- John Murray, VP Business Development, SanaClis
- Josh Murray, Chief Financial Officer and Head of Strategy, Orca Bio
- Søren Møller, Ph.D., Managing Partner, Seed Investments, Novo Holdings
- Elizabeth Naldi-Jacob, Vice President, Business Development and Licensing Head, HQ Transactions & Corporate Development, Merck
- Sarah Nam, Vice President, AI Strategy and Partnerships, AbbVie
- Arif Nathoo, CEO and Co-Founder, Komodo Health
- Judith Ng-Cashin, M.D., Chief Medical Officer, Novotech
- Benjamin Oakes, CEO, Scribe Therapeutics
- Wonhee Oh, VP HC Investment Banking, J.P. Morgan
- Naoki Okamura, President and Chief Executive Officer, Astellas
- Kent Payne, PhD, Managing Director, Wilmington PharmaTech
- Adam Pearson, Chief Strategy Officer, Astellas
- Saundra Pelletier, President, Chief Executive Officer, and Executive Director, Evofem Biosciences
- Jacob Petersen, SVP, Global Research, Novo Nordisk
- Thorsten Rall, Global Life Sciences Industry Leader, Capgemini
- Andrew Robertson, Vice President, Head of Global Regulatory Policy and Innovation, Takeda
- Christine Roth, Executive Vice President and Head of Global Product Strategy and Commercialization, Bayer
- Richard Saynor, Chief Executive Officer, Sandoz
- Dr. Chris Sheldon, Senior Vice President & Global Head of Business Development, GSK
- Christina Smolke, PhD, Co-Founder and CEO, Antheia
- Nitza Thomasson, Global Head of R&D Neurology, Servier
- Luc Truyen, Chief Medical Officer, argenx
- Heather Turner, CEO, LB Pharmaceuticals
- Josh Wallis, Vice President and General Manager, Fullspan Health
- Robert Zirkelbach, Chief Public Affairs Officer & Head of Strategic Initiatives, Pharmaceutical Research and Manufacturers of America (PhRMA)
Dates, venue and getting there
Fierce JPM Week 2027 runs in person on 12 and 13 January 2027 in San Francisco. The organizer's FAQ confirms the dates, and the virtual program follows on 20 to 22 January.
The venue page names the Hyatt Regency San Francisco at 5 Embarcadero Center. There's no attendee room block or special rate, so guests book the hotel directly.
The 2026 edition ran on 13 and 14 January 2026 at the same hotel. Antheia's January 2026 release placed its panel in the Hyatt Regency's Grand Ballroom A on 13 January.
Tickets and registration for Fierce JPM Week 2027
Fierce JPM Week sells two in-person passes, and all registrations need approval. The registration page, checked in November 2026, lists these prices.
- The pharma, biotech, med device and investor pass costs $695 at the early rate, which ends 11 December. It includes the event app, meals, the reception and the virtual event.
- The onsite price is $1,195 from 12 December.
- The vendor and service provider pass costs $2,195 for sales and business development staff.
- Group discounts of 15% to 25% apply to groups of two or more on the primary pass.
History of Fierce JPM Week
Questex started Fierce JPM Week as a virtual event when the industry couldn't travel. Its December 2020 release announced a three-day virtual edition for 11 to 13 January 2021.
For 2024, Questex expanded it to two days and moved it to the Hyatt Regency San Francisco. The same release said 2023 was the biggest edition in the event's history.
Questex runs other Fierce events too, including Fierce Biotech Week 2027 in Boston.
Resources for Fierce JPM Week 2027
These official pages cover registration, speaking, partnering and travel.
- Register for Fierce JPM Week 2027To see passes and approval rules.
- 2027 agendaFor sessions once they're posted.
- 2026 speakersFor last year's lineup.
- Call for speakersTo pitch a session.
- Partnering opportunitiesWith audience data and package types.
- Prospectus requestFor 2027 partnership details.
- Who's attendingFor companies represented in 2026.
- Venue informationFor the Hyatt Regency San Francisco.
- Event FAQFor dates, registration and speaker questions.